Related Experiment Videos
Results of hemipelvectomy for soft tissue sarcoma
The Netherlands Journal of Surgery
|May 1, 1981
Summary
Hemipelvectomy offers a viable treatment option for select soft tissue sarcoma patients, particularly for palliative care. Survival rates at one and five years were 69.2% and 42.6%, respectively, justifying its use in challenging cases.
Area of Science:
- Surgical Oncology
- Orthopedic Oncology
- Soft Tissue Sarcoma Treatment
Background:
- Hemipelvectomy is a major surgical procedure for pelvic tumors.
- Soft tissue sarcomas can present complex treatment challenges.
Purpose of the Study:
- To evaluate the outcomes of hemipelvectomy in patients with soft tissue sarcoma.
- To assess the efficacy and safety of hemipelvectomy for palliative and curative intent.
Main Methods:
- Retrospective review of 16 soft tissue sarcoma patients treated with hemipelvectomy.
- Analysis of surgical outcomes, complications, survival rates, and rehabilitation.
Main Results:
- Zero mortality rate; 50% morbidity, with most complications managed conservatively.
- Two cases of postoperative hemorrhage required intervention.
- One-year cumulative survival rate: 69.2%; five-year cumulative survival rate: 42.6%.
Conclusions:
- Hemipelvectomy is a justifiable treatment for carefully selected soft tissue sarcoma patients.
- The procedure has a role in palliative management for advanced disease.
- Successful rehabilitation is achievable for patients undergoing hemipelvectomy.